ARCHIVES

NCI Advisory Group Meetings for July

This article is from The Cancer Letter archive.

Vol. 01 No. 26 | June 27, 1975

Download PDF Visit The Full Archive

Related Articles

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

ASCO Breaks Ground For New HQ.

August 4, 2006

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980